CalciMedica, Cash Flow To Debt Ratio vs Begin Period Cash Flow Analysis

CALC Stock   2.76  0.01  0.36%   
CalciMedica, Common financial indicator trend analysis is way more than just evaluating CalciMedica, Common Stock prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether CalciMedica, Common Stock is a good investment. Please check the relationship between CalciMedica, Common Cash Flow To Debt Ratio and its Begin Period Cash Flow accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CalciMedica, Common Stock. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Cash Flow To Debt Ratio vs Begin Period Cash Flow

JavaScript chart by amCharts 3.21.15201420162018202020222024-4.40-4.35-4.30-4.25-4.20-4.15-4.10-4.05-4.00 2M4M6M8M10M12M14M16M18M20M22M24M26M28M30M32M34M
JavaScript chart by amCharts 3.21.15Cash Flow To Debt Ratiototal: -52.54494085708745Begin Period Cash Flowtotal: 81.3M

Cash Flow To Debt Ratio vs Begin Period Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of CalciMedica, Common Stock Cash Flow To Debt Ratio account and Begin Period Cash Flow. At this time, the significance of the direction appears to have weak contrarian relationship.
Cash Flow To Debt RatioBegin Period Cash FlowDiversified AwayCash Flow To Debt RatioBegin Period Cash FlowDiversified Away100%
The correlation between CalciMedica, Common's Cash Flow To Debt Ratio and Begin Period Cash Flow is -0.17. Overlapping area represents the amount of variation of Cash Flow To Debt Ratio that can explain the historical movement of Begin Period Cash Flow in the same time period over historical financial statements of CalciMedica, Common Stock, assuming nothing else is changed. The correlation between historical values of CalciMedica, Common's Cash Flow To Debt Ratio and Begin Period Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash Flow To Debt Ratio of CalciMedica, Common Stock are associated (or correlated) with its Begin Period Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Begin Period Cash Flow has no effect on the direction of Cash Flow To Debt Ratio i.e., CalciMedica, Common's Cash Flow To Debt Ratio and Begin Period Cash Flow go up and down completely randomly.

Correlation Coefficient

-0.17
Relationship DirectionNegative 
Relationship StrengthInsignificant

Cash Flow To Debt Ratio

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.
Most indicators from CalciMedica, Common's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into CalciMedica, Common Stock current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CalciMedica, Common Stock. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
The current year's Issuance Of Capital Stock is expected to grow to about 30.2 M, whereas Selling General Administrative is forecasted to decline to about 14.6 M.

CalciMedica, Common fundamental ratios Correlations

0.330.171.00.4-0.84-0.48-0.080.84-0.24-0.541.0-0.260.940.710.171.00.930.72-0.07-0.520.96-0.19-0.160.27-0.15
0.330.960.250.58-0.310.160.620.310.310.090.3-0.250.09-0.020.960.30.22-0.150.390.250.18-0.41-0.410.23-0.43
0.170.960.090.53-0.310.30.810.30.460.310.14-0.34-0.1-0.271.00.130.07-0.340.460.420.04-0.42-0.440.3-0.44
1.00.250.090.35-0.82-0.51-0.150.82-0.28-0.571.0-0.230.960.740.091.00.930.76-0.11-0.560.97-0.15-0.120.24-0.12
0.40.580.530.35-0.490.530.220.490.720.390.33-0.80.38-0.10.530.340.6-0.290.870.520.49-0.96-0.950.73-0.92
-0.84-0.31-0.31-0.82-0.490.11-0.27-1.0-0.140.1-0.820.58-0.74-0.3-0.31-0.82-0.83-0.39-0.20.15-0.880.390.39-0.510.34
-0.480.160.3-0.510.530.110.31-0.110.880.87-0.53-0.53-0.42-0.70.3-0.53-0.22-0.880.850.93-0.31-0.7-0.730.39-0.69
-0.080.620.81-0.150.22-0.270.310.270.510.55-0.09-0.4-0.38-0.610.81-0.11-0.19-0.480.340.51-0.15-0.24-0.280.38-0.25
0.840.310.30.820.49-1.0-0.110.270.15-0.090.82-0.590.740.290.30.820.830.380.21-0.140.88-0.4-0.390.52-0.34
-0.240.310.46-0.280.72-0.140.880.510.150.92-0.3-0.83-0.27-0.750.46-0.30.01-0.830.950.95-0.09-0.87-0.890.74-0.82
-0.540.090.31-0.570.390.10.870.55-0.090.92-0.58-0.65-0.57-0.930.31-0.58-0.33-0.930.770.96-0.39-0.61-0.640.57-0.57
1.00.30.141.00.33-0.82-0.53-0.090.82-0.3-0.58-0.210.930.730.141.00.910.76-0.14-0.570.95-0.12-0.090.22-0.09
-0.26-0.25-0.34-0.23-0.80.58-0.53-0.4-0.59-0.83-0.65-0.21-0.220.42-0.34-0.21-0.490.4-0.83-0.62-0.420.890.89-0.940.8
0.940.09-0.10.960.38-0.74-0.42-0.380.74-0.27-0.570.93-0.220.79-0.10.940.960.75-0.06-0.550.97-0.21-0.170.22-0.18
0.71-0.02-0.270.74-0.1-0.3-0.7-0.610.29-0.75-0.930.730.420.79-0.270.740.590.92-0.53-0.870.620.320.36-0.40.32
0.170.961.00.090.53-0.310.30.810.30.460.310.14-0.34-0.1-0.270.130.07-0.340.460.420.05-0.42-0.440.3-0.44
1.00.30.131.00.34-0.82-0.53-0.110.82-0.3-0.581.0-0.210.940.740.130.910.76-0.13-0.570.95-0.13-0.10.22-0.09
0.930.220.070.930.6-0.83-0.22-0.190.830.01-0.330.91-0.490.960.590.070.910.550.2-0.30.99-0.46-0.430.47-0.41
0.72-0.15-0.340.76-0.29-0.39-0.88-0.480.38-0.83-0.930.760.40.750.92-0.340.760.55-0.7-0.960.630.490.52-0.330.48
-0.070.390.46-0.110.87-0.20.850.340.210.950.77-0.14-0.83-0.06-0.530.46-0.130.2-0.70.860.08-0.96-0.970.74-0.93
-0.520.250.42-0.560.520.150.930.51-0.140.950.96-0.57-0.62-0.55-0.870.42-0.57-0.3-0.960.86-0.39-0.7-0.730.54-0.68
0.960.180.040.970.49-0.88-0.31-0.150.88-0.09-0.390.95-0.420.970.620.050.950.990.630.08-0.39-0.34-0.310.41-0.3
-0.19-0.41-0.42-0.15-0.960.39-0.7-0.24-0.4-0.87-0.61-0.120.89-0.210.32-0.42-0.13-0.460.49-0.96-0.7-0.341.0-0.80.95
-0.16-0.41-0.44-0.12-0.950.39-0.73-0.28-0.39-0.89-0.64-0.090.89-0.170.36-0.44-0.1-0.430.52-0.97-0.73-0.311.0-0.790.95
0.270.230.30.240.73-0.510.390.380.520.740.570.22-0.940.22-0.40.30.220.47-0.330.740.540.41-0.8-0.79-0.8
-0.15-0.43-0.44-0.12-0.920.34-0.69-0.25-0.34-0.82-0.57-0.090.8-0.180.32-0.44-0.09-0.410.48-0.93-0.68-0.30.950.95-0.8
Click cells to compare fundamentals

CalciMedica, Common Account Relationship Matchups

CalciMedica, Common fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets40.7M101.8M69.1M39.7M12.2M11.6M
Other Current Liab7.6M4.5M3.5M1.7M2.5M3.1M
Total Current Liabilities12.3M7.0M4.1M3.7M4.0M4.9M
Total Stockholder Equity28.4M94.8M65.0M36.0M8.2M7.7M
Property Plant And Equipment Net2.0M1.9M2.0M195K167K158.7K
Net Debt(15.9M)(33.4M)(13.4M)(17.1M)(5.5M)(5.8M)
Retained Earnings(105.8M)(133.4M)(169.2M)(204.8M)(146.1M)(153.4M)
Accounts Payable4.6M2.5M527K2.9M1.4M1.9M
Cash15.9M33.4M13.4M17.3M5.5M5.3M
Non Current Assets Total4.4M2.6M2.0M1.6M580K551K
Non Currrent Assets Other2.4M580K29K1.4M413K392.4K
Cash And Short Term Investments36.0M95.0M63.7M39.1M11.2M10.7M
Common Stock Shares Outstanding1.0M472.7K1.5M1.5M4.5M4.7M
Liabilities And Stockholders Equity40.7M101.8M69.1M39.7M12.2M11.6M
Other Current Assets315K4.2M3.4M1.0M367K348.7K
Other Stockholder Equity2.9M228.2M234.2M40.4M154.2M121.4M
Total Liab12.3M7.0M4.1M3.7M4.0M4.9M
Total Current Assets36.3M99.2M67.1M39.7M11.6M11.0M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether CalciMedica, Common Stock offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of CalciMedica, Common's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Calcimedica, Common Stock Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Calcimedica, Common Stock Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CalciMedica, Common Stock. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CalciMedica, Common. If investors know CalciMedica, will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CalciMedica, Common listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.11)
Return On Assets
(0.65)
Return On Equity
(0.84)
The market value of CalciMedica, Common Stock is measured differently than its book value, which is the value of CalciMedica, that is recorded on the company's balance sheet. Investors also form their own opinion of CalciMedica, Common's value that differs from its market value or its book value, called intrinsic value, which is CalciMedica, Common's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CalciMedica, Common's market value can be influenced by many factors that don't directly affect CalciMedica, Common's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CalciMedica, Common's value and its price as these two are different measures arrived at by different means. Investors typically determine if CalciMedica, Common is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CalciMedica, Common's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Trending Assets

WVVI
Willamette Valley
3.33  0.05  1.52 
TBVPY
Thai Beverage PCL
33.67  0.00  0.00 
SCL
Stepan Company
68.84  0.51  0.75 
CDXS
Codexis
5.21  0.02  0.39 
News Freq…Investor S…